| {"0": "Electron transport chain oxphos system in mitochondria", "1": "Mitochondrial complex i assembly model oxphos system", "2": "Mitochondrial complex iv assembly", "3": "Sphingolipid metabolism integrated pathway", "4": "Sphingolipid pathway", "5": "Sphingolipid metabolism overview", "6": "Overlap between signal transduction pathways contributing to lmna laminopathies", "7": "Nonalcoholic fatty liver disease", "8": "Ferroptosis", "9": "Glycosaminoglycan degradation", "10": "Degradation pathway of sphingolipids including diseases", "11": "Cholesterol metabolism with bloch and kandutschrussell pathways", "12": "Copper homeostasis", "13": "Allograft rejection", "14": "Oxidative phosphorylation", "15": "Glycerophospholipid biosynthetic pathway", "16": "Cholesterol biosynthesis with skeletal dysplasias", "17": "Mitochondrial immune response to sarscov2", "18": "Metapathway biotransformation phase i and ii", "19": "Cholesterol biosynthesis pathway", "20": "Alzheimers disease and mirna effects", "21": "Alzheimers disease", "22": "Glycosylation and related congenital defects", "23": "Type i collagen synthesis in the context of osteogenesis imperfecta", "24": "Spinal cord injury", "25": "Vitamin d receptor pathway", "26": "Striated muscle contraction pathway", "27": "Ppar signaling pathway"} |